Certain bacteria, viruses, fungi, and protozoa which do not usually cause infections in healthy people, can cause infections in people with a weakened immune system; these are called opportunistic infections.

Classification of opportunistic infection in HIV/AIDS
Bacterial and mycobacterial infections
Fungal infections
-
Aspergillosis
-
Candidiasis (thrush)
-
Coccidioidomycosis
-
Cryptococcal Meningitis
-
Histoplasmosis
Viral infections
-
Cytomegalovirus (CMV)
-
Hepatitis
-
Herpes Simplex (HSV, genital herpes)
-
Herpes Zoster (HZV, shingles)
-
Human Papiloma Virus (HPV, genital warts, cervical cancer)
-
Molluscum Contagiosum
-
Oral Hairy Leukoplakia (OHL)
Protozoal infections
Other complications
-
AIDS dementia complex
-
Apthous ulcers
-
Malabsorption
-
Peripheral neuropathy
HIV associated malignancy
-
Kaposi sarcoma
-
Lymphoma
-
Squamous cell carcinoma
Prevention of HIV related opportunistic infections
Prophylaxis against opportunistic infections in patients with AIDS
|
Infection
|
Drug used
|
Indications
|
|
Pneumocystis carinii pneumonia (PCP)
|
Trimethoprim-sulfamethaxazole- DS (cotrimoxazole)
|
CD4 count <200 cells thrush; unexplained fever for more than two weeks; history of PCP
|
|
Toxoplasmosis
|
Trimethoprim-sulfamethaxazole(double-strength)
|
CD4 count <100 cells and Toxoplasma sero-positive
|
|
Mycobacterium avium complex
|
Azithromycin
|
CD4 count <50 cells
|
|
Histoplasmosis
|
Itraconazole
|
CD4 count <100 cells and lives in an endemic area
|
Discontinuation of preventive treatment
-
Preventive treatment for mycobacterium avium complex infection is usually discontinued when the T cell count is >100 cells/µL for 3 months.
-
Preventive treatment for pneumocystis and toxoplasmosis is usually discontinued when the T cell count is >200 cells/µL for 3 months.
The World Health Organization (WHO) recommends that, in resource-limited settings, the following groups of people should begin taking cotrimoxazole:
-
HIV-exposed infants/children, starting at 4-6 weeks after birth or at first contact with health care, and continued until HIV infection is excluded
-
HIV-positive children less than 1 year old
-
HIV-positive children aged 1-4 years who have mild, advanced or severe symptoms of HIV disease, or a CD4 count below 25%
-
HIV-positive adults and adolescents who have mild, advanced or severe symptoms of HIV disease, or a CD4 count below 350 cells per ml
-
HIV-positive people with a history of treated PCP.